Major GI events among elderly chronic users of COX-2s and non-selective NSAIDs, with/without aspirin

被引：0
|
作者：
Wang, J
Mullins, CD
Naradzay, JF
Howard, K
机构：
[1] Univ Maryland, Sch Pharm, Baltimore, MD 21201 USA
[2] Pfizer, New York, NY USA
来源：
VALUE IN HEALTH | 2006年 / 9卷 / 03期
关键词：
D O I：
10.1016/S1098-3015(10)64440-3
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A44 / A44
页数：1
相关论文
共 50 条
  • [31] Short-term administration of non-selective and selective cox-2 nsaids do not interfere with bone repair in rats
    Mariza Akemi Matsumoto
    Angelita De Oliveira
    Paulo Domingos Ribeiro Junior
    Hugo Nary Filho
    Daniel Araki Ribeiro
    Journal of Molecular Histology, 2008, 39 : 381 - 387
  • [32] Effect of concomitant use of gastroprotective agents with non-selective NSAIDs and acetaminophen on GI hospitalizations among the elderlly in Quebec, Canada.
    Rahme, Elham
    Barkun, Alan N.
    Nedjar, Hacene
    Gaugris, Sabine
    Watson, Douglas J.
    ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S109 - S109
  • [33] Co-prescription of gastroprotective agents in patients taking non-selective NSAIDs or COX-2 selective inhibitors analysis of prescriptions
    Pasina, L.
    Nobili, A.
    Tettamanti, M.
    Riva, E.
    Lucca, U.
    Picinelli, R.
    Defendi, L.
    Perego, L.
    Lucifora, S.
    Bulla, C.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2010, 48 (11) : 735 - 743
  • [34] The balance between severe cardiovascular and gastrointestinal events among users of selective and non-selective non steroidal anti-inflammatory drugs
    Van der Linden, M. W.
    Van der Bij, S.
    Welsing, P.
    Kuipers, E.
    Herings, R. M.
    VALUE IN HEALTH, 2008, 11 (03) : A153 - A153
  • [35] The balance between severe cardiovascular and gastrointestinal events among users of selective and non-selective non steroidal anti-inflammatory drugs
    van der Linden, Michiel W.
    Kuipers, E. J.
    Sukel, Myrthe P.
    Herings, Ron M.
    Gaugris, Sabine
    GASTROENTEROLOGY, 2008, 134 (04) : A625 - A625
  • [36] Aspirin use in patients taking selective COX-2 inhibitors or non-selective NSAID therapy in a managed care setting
    Sarawate, C
    Grochulski, D
    Barron, JJ
    Griffith, CR
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2004, 99 (10): : S238 - S238
  • [37] Evaluating overall cardiovascular and gastrointestinal risks and benefits of cox-2 selective inhibitors and non-selective NSAIDs using a decision analytic model
    Mittmann, N.
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 268 - 269
  • [38] GI safety of a non-selective NSAID vs a cox-2 inhibitor: Equivalency of ibuprofen and celecoxib in an OTC setting
    Ashraf, E
    Cooper, S
    Marinucci, L
    Doyle, G
    Berlin, R
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2002, 97 (09): : S45 - S45
  • [39] The balance between severe cardiovascular and gastrointestinal events among users of selective and non-selective non-steroidal anti-inflammatory drugs
    van der Linden, M. W.
    van der Bij, S.
    Welsing, P.
    Kuipers, E. J.
    Herings, R. M. C.
    ANNALS OF THE RHEUMATIC DISEASES, 2009, 68 (05) : 668 - 673
  • [40] Risks and benefits of COX-2 inhibitors versus non-selective NSAIDs: Does their cardiovascular risk exceed their gastrointestinal benefit?
    Rahme, Elham
    Nedjar, Hacene
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2006, 15 : S61 - S61
12345